Welcome to UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. If you are thinking about studying with us, applications to our flagship MSc Cancer programme are open until 28 July for September 2017 entry, plus a new and unique undergraduate degree BSc Cancer Biomedicine starting 2018.
News and features
Scientists at UCL, UCLH and the Francis Crick Institute have found that unstable chromosomes within lung tumours increase the risk of cancer returning after surgery, and have used this new knowledge to detect relapse long before standard testing.
Published: Apr 27, 2017 5:55:03 PM
A scientific collaboration between UCL, Dana-Farber Cancer Institute, UCSF Medical Centre and the UCL Cancer Institute / Royal Free Hospital London has been awarded a $1.2m accelerator grant from the Neuroendocrine Tumor Research Foundation (NETRF) to help advance research into small intestine neuroendocrine tumours (SI-NETs).
Published: Apr 27, 2017 4:16:14 PM
A scientific team led by UCL has found a hotspot in ‘junk’ DNA that appears to be controlling how a nearby cancer-causing gene behaves, according to research published in the journal, Blood.
Published: Mar 20, 2017 5:29:56 PM
New research led by UCL has revealed how certain cancer cells are able to rewire the TRAIL cell signalling pathway to help promote tumour growth and avoid immune recognition. The findings, published in Molecular Cell, provide a compelling case for exploring the potential of blocking TRAIL as a treatment for some cancers.
Published: Mar 14, 2017 10:35:54 AM
Support our work
Help us to continue the research that will lead to the breakthroughs in therapies for cancer patients. Support us >
Action for equality and diversity
UCL Cancer Institute holds an Athena SWAN silver award in recognition of it's commitment to advancing equality, diversity and careers.